StemCells, Inc. (NASDAQ:STEM)

CAPS Rating: 2 out of 5

A biopharmaceutical company that operates in one segment, the development of novel cell-based therapeutics designed to treat human diseases and disorders.

Recs

0
Player Avatar FRESHTASTIC (21.61) Submitted: 11/22/2010 2:39:12 AM : Outperform Start Price: $11.50 STEM Score: -104.05

nice

Featured Broker Partners


Advertisement